Cover Image
市場調查報告書

成藥的全球市場的未來預測 (2018∼2028年):咳嗽、感冒、過敏藥,止痛藥,腸胃藥,皮膚藥,眼睛保健品用品,戒煙輔助品等

Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies

出版商 Visiongain Ltd 商品編碼 320889
出版日期 內容資訊 英文 201 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
成藥的全球市場的未來預測 (2018∼2028年):咳嗽、感冒、過敏藥,止痛藥,腸胃藥,皮膚藥,眼睛保健品用品,戒煙輔助品等 Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies
出版日期: 2018年04月05日 內容資訊: 英文 201 Pages
簡介

本報告提供全球成藥市場相關分析,產品、市場概要和最新趨勢,市場規模趨勢預測 (今後11年份),各產品、各地區的詳細趨勢,市場定性分析 (促進、阻礙因素,市場向心力等),主要企業的簡介,今後的市場成長可能性等彙整資料。

第1章 分析概要

第2章 成藥的概要

  • 成藥是什麼?
  • 成藥的分類
  • 成藥的必要條件
  • OTC交換器
  • 成藥的製造與流通
  • 成藥相關各國的法律規章

第3章 全球成藥市場預測 (今後11年份)

  • 成藥市場現狀

第4章 全球成藥市場:各產品的預測 (今後11年份)

  • 概要
  • 咳嗽,感冒,過敏
    • 抗過敏產品
  • 止痛藥 (內服藥物,外用藥)
  • 腸胃藥
  • 皮膚藥
    • 刀傷,外傷
    • 粉刺
    • 皮疹,癢,皮膚炎/濕疹
    • 皮膚真菌感染疾病
    • 痔核
    • 其他
  • 眼睛保健品用品
    • 乾眼症症候群
    • 細菌性結膜炎
    • 眼過敏/過敏性結膜炎
    • 眼過敏/過敏性結膜炎的治療藥
  • 戒煙輔助品
  • 其他

第5章 全球成藥市場:各地區、各國預測 (今後11年份)

  • 各地區的市場預測 (今後11年份)
  • 北美市場 (美國,加拿大,墨西哥)
  • 南美市場 (巴西,阿根廷,巴拉圭,玻利維亞等)
  • 歐洲市場 (法國,德國,英國,西班牙,義大利等)
  • 亞太地區市場 (日本,印度,澳洲,泰國等)
  • 其他的國家的市場 (RoW:中東,非洲等)

第6章 成藥市場定性分析

  • 成藥市場SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅
  • 波特的五力分析

第7章 成藥市場代表性企業

  • Bayer AG
  • GlaxoSmithKline PLC (GSK Consumer Care)
  • Johnson & Johnson
  • Perrigo Company PLC
  • 第一三共
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A.
  • Reckitt Benckiser Group PLC
  • Cipla Inc.

第8章 結論

第9章 詞彙表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0298

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 84 tables and 79 figures- all unavailable elsewhere.

The 201-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global OTC Pharmaceutical Market forecasts from 2018-2028

This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:

  • Analgesics
  • Cough, cold and allergy products
  • Dermatological products
  • Gastrointestinal products
  • Eye Care
  • Smoking Cessation Aids
  • Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

This report provides individual revenue forecasts to 2028 for these regional and national markets:

  • North America: the US, Canada, Mexico
  • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
  • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
  • Rest of the World: Middle East, Africa, Other Countries

Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market

This report discusses the leading companies in the Global OTC Pharmaceutical market

  • Bayer AG
  • GlaxoSmithKline (GSK) Consumer Care
  • Perrigo Company PLC
  • Johnson & Johnson
  • Daiichi Sankyo Co., Ltd
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A
  • Reckitt Benckiser Group PLC
  • Cipla, Inc.

Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today ‘Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies’.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. The OTC Pharmaceuticals Market Overview
  • 1.2. Research Methodology
  • 1.3. Global OTC Pharmaceutical Market Segmentation
  • 1.4. Why You Should Read This Report
  • 1.5. How this report delivers?
  • 1.6. Key Questions Answered by This Analytical Report
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Who is This Report For?
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Introduction to OTC Pharmaceuticals

  • 2.1. What Are OTC Pharmaceuticals?
  • 2.2. Classification of OTC Pharmaceuticals
  • 2.3. What are the Requirements for an OTC Pharmaceutical Drug?
  • 2.4. OTC Switching
    • 2.4.1. How Is a Drug Switched from Prescription to OTC?
  • 2.5. Manufacturing and Distribution of OTC Pharmaceuticals
  • 2.6. Regulation of OTC Pharmaceuticals
    • 2.6.1. Regulation of OTC Pharmaceuticals in the US
    • 2.6.2. Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
    • 2.6.3. Regulation of OTC Pharmaceuticals in Europe
    • 2.6.4. Regulation of OTC Pharmaceuticals in China
    • 2.6.5. Regulation of OTC Pharmaceuticals in Others Countries

3. Global OTC Pharmaceutical Market Forecast 2018-2028

  • 3.1. The Current State of the OTC Pharmaceutical Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2018-2028

  • 4.1. Overview
  • 4.2. Cough, Cold and Allergy
    • 4.2.1. Anti-Allergy Products
  • 4.3. Analgesics
    • 4.3.1. Internal Analgesics
    • 4.3.2. External Analgesics
  • 4.4. Gastrointestinal
  • 4.5. Dermatological
    • 4.5.1. Minor Cuts and Wounds
    • 4.5.2. Acne
    • 4.5.3. Rashes, Itchy Skin, and Dermatitis/Eczema
    • 4.5.4. Cold Sores
    • 4.5.5. Warts
    • 4.5.6. Fungal Skin Infections
    • 4.5.7. Haemorrhoids
    • 4.5.8. Other Dermatological Products
  • 4.6. Eye Care
    • 4.6.1. Dry Eye Syndrome
    • 4.6.2. Bacterial Conjunctivitis
    • 4.6.3. Ocular Allergy and Allergic Conjunctivitis
    • 4.6.4. Treatment of Ocular Allergy/ Allergic Conjunctivitis
  • 4.7. Smoking Cessation Aids
  • 4.8. Other Products

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2018-2028

  • 5.1. Global OTC Pharmaceuticals Market: Regional Forecast, 2018-2028
  • 5.2. North American OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.2.1. USA OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.2.2. Canada OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.2.3. Mexico OTC Pharmaceutical Market Forecasts 2018-2028
  • 5.3. South American OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.3.1. Brazil OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.3.2. Argentina OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.3.3. Paraguay OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.3.4. Bolivia OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.3.5. Rest of South America OTC Pharmaceutical Market Forecasts 2018-2028
  • 5.4. European OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.1. France OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.2. Germany OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.3. UK OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.4. Spain OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.5. Italy OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.4.6. Rest of Europe OTC Pharmaceutical Market Forecasts 2018-2028
  • 5.5. Asia-Pacific OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.1. China OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.2. Japan OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.3. India OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.4. Australia OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.5. Thailand OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.5.6. Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2018-2028
  • 5.6. Rest of World OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.6.1. Middle East OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.6.2. Africa OTC Pharmaceutical Market Forecasts 2018-2028
    • 5.6.3. Other Countries OTC Pharmaceutical Market Forecasts 2018-2028

6. Qualitative Analysis of the OTC Pharmaceutical Market, 2018-2028

  • 6.1. SWOT Analysis of the OTC Pharmaceutical Market
  • 6.2. Strengths
    • 6.2.1. Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
      • 6.2.1.1. Manufacturers Can Reap OTC Sales Benefits
      • 6.2.1.2. Third Party Payers: Reducing the Cost Burden
      • 6.2.1.3. Healthcare Systems: Pushing the Cost to the Consumer
    • 6.2.2. Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
    • 6.2.3. Regulators Are Encouraging OTC Approvals
    • 6.2.4. Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
    • 6.2.5. Deterring the Consumption of Counterfeit Drugs
    • 6.2.6. Cultural Changes Will Support Self-Medication with OTC Medicines
  • 6.3. Weaknesses
    • 6.3.1. Pharma Companies Remain Focused on Prescription Drugs
    • 6.3.2. Manufacturing Problems Affects Sales and Reputation of OTC Drugs
    • 6.3.3. OTC Products are Vulnerable to Price Controls by Governments
    • 6.3.4. Downward Cost Pressures of OTC Drugs
  • 6.4. Opportunities
    • 6.4.1. Demographic and Economic Changes Will Create Growth Opportunities
    • 6.4.2. New OTC Switch Categories
    • 6.4.3. Strong Growth in Emerging Markets
    • 6.4.4. New Healthcare Technologies May enable OTC Approvals
    • 6.4.5. Opportunities to Drive Sales via Social Media and Online Marketing
    • 6.4.6. Self-Medication Can Reduce the Under Treatment of Disease
  • 6.5. Threats
    • 6.5.1. Competition from Private-Label Brands Will Reduce Profitability
    • 6.5.2. Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
    • 6.5.3. Resistance to OTC Switching from Some Groups in Certain Countries
  • 6.6. Porter's Five Forces Analysis of the OTC Pharmaceutical Market
    • 6.6.1. Rivalry Among Competitors [High]
    • 6.6.2. Threat of New Entrants [Medium]
    • 6.6.3. Power of Suppliers [Low]
    • 6.6.4. Power of Buyers [Medium]
    • 6.6.5. Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceutical Market

  • 7.1. Bayer AG
    • 7.1.1. Bayer AG: Company Overview
    • 7.1.2. Bayer AG: Product Portfolio
    • 7.1.3. Bayer AG: Recent Developments
  • 7.2. GlaxoSmithKline PLC (GSK Consumer Care)
    • 7.2.1. GlaxoSmithKline PLC: Company Overview
    • 7.2.2. GlaxoSmithKline PLC: Product Portfolio
    • 7.2.3. GlaxoSmithKline PLC: Recent Developments
  • 7.3. Johnson & Johnson
    • 7.3.1. Johnson & Johnson: Company Overview
    • 7.3.2. Johnson & Johnson: Product Portfolio
    • 7.3.3. Johnson & Johnson: Recent Developments
  • 7.4. Perrigo Company PLC
    • 7.4.1. Perrigo Company PLC: Company Overview
    • 7.4.2. Perrigo Company PLC: Product Portfolio
    • 7.4.3. Perrigo Company PLC: Recent Developments
  • 7.5. Daiichi Sankyo Co., Ltd.
    • 7.5.1. Daiichi Sankyo Co., Ltd.: Company Overview
    • 7.5.2. Daiichi Sankyo Co., Ltd.: Recent Developments
  • 7.6. Pfizer Inc.
    • 7.6.1. Pfizer Inc.: Company Overview
    • 7.6.2. Pfizer Inc.: Product Portfolio
    • 7.6.3. Pfizer Inc.: Recent Developments
  • 7.7. Procter & Gamble
    • 7.7.1. Procter & Gamble: Company Overview
    • 7.7.2. Procter & Gamble: Product Portfolio
    • 7.7.3. Procter & Gamble: Recent Developments
  • 7.8. Sanofi S.A.
    • 7.8.1. Sanofi S.A.: Company Overview
    • 7.8.2. Sanofi S.A.: Product Portfolio
    • 7.8.3. Sanofi S.A: Recent Developments
  • 7.9. Reckitt Benckiser Group PLC
    • 7.9.1. Reckitt Benckiser Group PLC: Company Overview
    • 7.9.2. Reckitt Benckiser Group PLC: Product Portfolio
    • 7.9.3. Reckitt Benckiser Group PLC: Recent Developments
  • 7.10. Cipla Inc.
    • 7.10.1. Cipla Inc.: Company Overview
    • 7.10.2. Cipla Inc.: Product Portfolio
    • 7.10.3. Cipla Inc.: Recent Developments
  • 7.11. List of Key Players in Global OTC Market

8. Conclusions

  • 8.1. The World OTC Pharmaceutical Market in 2016-2017
    • 8.1.1. The Leading OTC Product Categories
    • 8.1.2. Leading National Markets: Emerging Market Represent a Large Proportion
    • 8.1.3. The Global OTC Market Growth Factors
    • 8.1.4. Potential OTC Switching, 2018-2028
    • 8.1.5. Emerging OTC Markets
  • 8.2. Concluding Remarks

9. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: OTC Pharmaceuticals: Overview of Submarkets
  • Figure 2.1: The OTC Pharmaceutical Supply Chain, 2018
  • Figure 3.1: OTC Pharmaceutical Market, by Product, ($bn), 2018-2028
  • Figure 3.2: OTC Pharmaceutical Market, by Geography, ($bn), 2018-2028
  • Figure 4.1: OTC Pharmaceutical Market, by Product, Market Share (%), 2017
  • Figure 4.2: OTC Pharmaceutical Market, by Product, Forecast ($bn) 2018-2028
  • Figure 4.3: OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2018-2028
  • Figure 4.4: OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2018-2028
  • Figure 4.5: OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2018-2028
  • Figure 4.6: OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2018-2028
  • Figure 4.7: OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2018-2028
  • Figure 4.8: OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2018-2028
  • Figure 4.9: OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2018-2028
  • Figure 5.1: OTC Pharmaceutical Market Forecast, by Geography ($bn) 2018-2028
  • Figure 5.2: Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2017
  • Figure 5.3: North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028
  • Figure 5.4: North America OTC Pharmaceutical Market, by Country, Market Share (%), 2017
  • Figure 5.5: USA OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.6: Canada OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.7: Mexico OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.8: South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028
  • Figure 5.9: South America OTC Pharmaceutical Market, by Country, Market Share (%), 2017
  • Figure 5.10: Brazil OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.11: Argentina OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.12: Paraguay OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.13: Bolivia OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.14: Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.15: Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2018-2028
  • Figure 5.16: Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.17: France OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.18: Germany OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.19: UK OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.20: Spain OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.21: Italy OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.22: Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.23: Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2018-2028
  • Figure 5.24: Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.25: China OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.26: Japan OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.27: India OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.28: Australia OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.29: Thailand OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.30: Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.31: RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028
  • Figure 5.32: Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.33: Middle East OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.34: Africa OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 5.35: Other Countries OTC Pharmaceutical Market Forecast ($bn) 2018-2028
  • Figure 6.1: Porter's Five Analysis of the OTC Pharmaceutical Market , 2017
  • Figure 7.1: Bayer AG, Revenue, ($million), 2012-2016
  • Figure 7.2: Bayer AG, Product Segments Share (%), 2016
  • Figure 7.3: Bayer AG, Geographic Presence Share (%), 2016
  • Figure 7.4: GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
  • Figure 7.5: GlaxoSmithKline PLC, Product Segments Share (%), 2016
  • Figure 7.6: GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
  • Figure 7.7: Johnson & Johnson, Revenue, ($million), 2012-2016
  • Figure 7.8: Johnson & Johnson, Product Segments Share (%), 2016
  • Figure 7.9: Johnson & Johnson, Geographical Presence Share (%), 2016
  • Figure 7.10: Perrigo Company PLC, Revenue, ($million), 2012-2016
  • Figure 7.11: Perrigo Company PLC, Product Segments Share (%), 2016
  • Figure 7.12: Perrigo Company PLC, Geographical Presence Share (%), 2016
  • Figure 7.13: Daiichi Sankyo Co., Ltd., Revenue, ($million), 2013-2017
  • Figure 7.14: Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2017
  • Figure 7.15: Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2017
  • Figure 7.16: Pfizer Inc., Revenue, ($million), 2012-2016
  • Figure 7.17: Pfizer Inc., Product Segments Share (%), 2016
  • Figure 7.18: Pfizer Inc., Geographical Presence Share (%), 2016
  • Figure 7.19: Procter & Gamble, Revenue, ($million), 2012-2016
  • Figure 7.20: Procter & Gamble, Product Segments Share (%), 2017
  • Figure 7.21: Procter & Gamble, Geographical Presence Share (%), 2017
  • Figure 7.22: Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 7.23: Sanofi S.A., Product Segments Share (%), 2016
  • Figure 7.24: Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 7.25: Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016
  • Figure 7.26: Reckitt Benckiser Group PLC, Product Segments Share (%), 2016
  • Figure 7.27: Cipla Inc., Revenue, ($million), 2012-2016
  • Figure 7.28: Cipla Inc., Product Segments Share (%), 2016
  • Figure 8.1: Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2018-2028
  • Figure 8.2: Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2018-2028

List of Tables

  • Table 3.1: Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2018-2028
  • Table 4.1: Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2018-2028
  • Table 4.2: OTC Cough, Cold and Allergy Active Ingredients, 2018
  • Table 4.3: Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.4: OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2018-2028
  • Table 4.5: OTC Internal Analgesic Active Ingredients, 2017
  • Table 4.6: OTC External Analgesic Active Ingredients, 2017
  • Table 4.7: Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.8: OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 4.9: Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.10: OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 4.11: OTC Antifungal Active Ingredients, 2017
  • Table 4.12: Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.13: OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2018-2028
  • Table 4.14: OTC Dry Eye Syndrome Active Ingredients, 2017
  • Table 4.15: OTC Bacterial Conjunctivitis Active Ingredients, 2017
  • Table 4.16: OTC Ocular Allergy Active Ingredients, 2017
  • Table 4.17: Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.18: OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 4.19: OTC Smoking Cessation Aid Active Ingredients, 2017
  • Table 4.20: Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.21: OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 4.22: Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2018-2028
  • Table 4.23: OTC Pharmaceutical Market for Other Products Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 5.1: OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2018-2028
  • Table 5.2: North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028
  • Table 5.3: USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.4: Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.5: Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.6: South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028
  • Table 5.7: Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.8: Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.9: Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.10: Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.11: Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.12: European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028
  • Table 5.13: France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.14: Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.15: UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.16: Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.17: Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.18: Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.19: Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028
  • Table 5.20: China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.21: Selected Leading Companies in the Japanese OTC Pharma Market, 2017
  • Table 5.22: Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.23: India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.24: Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.25: Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.26: Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.27: Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028
  • Table 5.28: Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.29: Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 5.30: Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028
  • Table 7.1: Bayer AG: Company Overview
  • Table 7.2: Bayer AG: Product Portfolio
  • Table 7.3: Bayer AG: Recent Developments
  • Table 7.4: GlaxoSmithKline PLC: Company Overview
  • Table 7.5: GlaxoSmithKline PLC: Product Portfolio
  • Table 7.6: GlaxoSmithKline PLC: Recent Developments
  • Table 7.7: Johnson & Johnson: Company Overview
  • Table 7.8: Johnson & Johnson: Product Portfolio
  • Table 7.9: Johnson & Johnson: Recent Developments
  • Table 7.10: Perrigo Company PLC: Company Overview
  • Table 7.11: Perrigo Company PLC: Product Portfolio
  • Table 7.12: Perrigo Company PLC: Recent Developments
  • Table 7.13: Daiichi Sankyo Co., Ltd.: Company Overview
  • Table 7.14: Daiichi Sankyo Co., Ltd.: Recent Developments
  • Table 7.15: Pfizer Inc.: Company Overview
  • Table 7.16: Pfizer Inc.: Product Portfolio
  • Table 7.17: Pfizer Inc.: Recent Developments
  • Table 7.18: Procter & Gamble: Company Overview
  • Table 7.19: Procter & Gamble: Product Portfolio
  • Table 7.20: Procter & Gamble: Recent Developments
  • Table 7.21: Sanofi S.A.: Company Overview
  • Table 7.22: Sanofi S.A.: Product Portfolio
  • Table 7.23: Sanofi S.A: Recent Developments
  • Table 7.24: Reckitt Benckiser Group PLC: Company Overview
  • Table 7.25: Reckitt Benckiser Group PLC: Product Portfolio
  • Table 7.26: Reckitt Benckiser Group PLC: Recent Developments
  • Table 7.27: Cipla Inc.: Company Overview
  • Table 7.28: Cipla Inc.: Product Portfolio
  • Table 7.29: Cipla Inc.: Recent Developments
  • Table 7.30: List of Key Players in Global OTC Market

Companies Listed

  • Abbott Laboratories
  • Achelios Therapeutics, Inc.
  • Acrux
  • Aiping Pharmaceutical
  • Akron Pharmaceuticals
  • Allegiant Health
  • Alvogen pharmaceuticals company
  • American Health
  • Amgen
  • Amol Pharmaceuticals Private Limited
  • Apotex
  • Arena Pharmaceuticals
  • Aspen Australia
  • AstraZeneca plc
  • Bal Pharma ltd.
  • Bayer AG
  • BePharBel
  • Beximco Pharmaceuticals
  • Binnopharm
  • BioGaia
  • Bliss GVS Pharma Ltd.
  • Bristol Myers Squibb
  • Bukwang Pharm. Co., Ltd.
  • Canagen Pharmaceuticals Inc
  • Chameleon Pharma
  • Chr. Hansen
  • Cipla Inc.
  • Cipla Limited
  • CoLucid Pharmaceuticals
  • Company Name
  • Company Name
  • CR Pharmaceutical
  • Crescent Pharma
  • Daiichi Sankyo
  • Delavau Pharmaceutical Partners
  • Dr. Reddy's Laboratories
  • Eisai Co., Ltd.
  • eKapija
  • GCP Laboratories
  • Gilead Medicines
  • GlaxoSmithKline PLC
  • Guangzhou Pharmaceutical Company Ltd
  • Guardian Drug Company
  • Hiran Agroceuticals Private Limited
  • Hi-Tech Pharmaceuticals
  • iNova Pharmaceuticals
  • Ion Labs
  • Johnson & Johnson
  • Juno Pharmaceuticals
  • Lipa Pharmaceuticals
  • LNK International, Inc
  • Marksans Pharma
  • Mayne Pharma
  • Moberg Pharma
  • Mylan
  • Nexgen Pharma Inc.
  • Olainfarm
  • Olive Healthcare
  • Perrigo
  • Pfizer Inc.
  • Pharma Medico's
  • Procter & Gamble
  • Purzer Pharmaceutical Co., Ltd.
  • Reckitt Benckiser Group PLC
  • Samson Pharmaceuticals, Inc.
  • Sandz Australia
  • Sanofi S.A
  • Sarvotham Care Limited
  • Sentiss Pharmaceuticals, LLC
  • Sterling Pharmaceutical
  • Supreme Pharma Healthcare Pvt. Ltd.
  • Trividia Manufacturing Solutions, Inc.
  • TSI Pharmaceuticals
  • Valenta Pharm
  • Vifor Pharma
  • Vista Pharmaceuticals
  • Wellona Pharma

List of Organizations:

  • China Food and Drug Administration (CFDA)
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA) [US]
  • Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Germany]
  • Ministry of Health, Labor and Welfare (MHLW) [Japan]
  • National Health Service (NHS) [UK]
  • World Health Organization (WHO)
Back to Top